COVID-19 and its Cardiac and Neurological Complications among Ontario Visible Minorities

Joseph Y Chu1, Yosuf Kaliwal2, Maria Koh2

  • 1Division of Neurology, Department of Medicine, Toronto Western Hospital-University Health Network and William Osler Health System, University of Toronto, Toronto, Canada.

Insights

COVID-19 outcomes differed significantly between Chinese and South Asian populations in Ontario. Chinese individuals experienced higher mortality and neurological complications, while South Asians had lower mortality rates.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Limited data existed on COVID-19 complications in Ontario's Chinese and South Asian communities.
  • Visible minorities faced a disproportionate impact from the pandemic.

Purpose of the Study:

  • To systematically investigate the epidemiology of COVID-19.
  • To analyze cardiac and neurological complications in Ontario's Chinese and South Asian populations.
  • To compare outcomes with the general population.

Main Methods:

  • Population-based retrospective study (Jan 1 - Sep 30, 2020).
  • Identified COVID-19 positive Chinese and South Asians using a last name algorithm.
  • Analyzed demographics, cardiac, and neurological complications, hospitalizations, and emergency visits.

Main Results:

  • Chinese (older) had higher 30-day mortality (8.1%) vs. general population (5.0%).
  • Chinese showed higher rates of neurological complications (160/10,000) compared to the general population (48/10,000).
  • South Asians (younger) had lower 30-day mortality (2.1%) and fewer cardiac complications (64/10,000) than the general population (112/10,000).

Conclusions:

  • Significant demographic and outcome differences observed in Chinese and South Asians with COVID-19.
  • COVID-19 presented distinct challenges for these minority groups in Ontario.
  • Further research is needed to understand these disparities.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
102
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
43
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
115
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
158
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
143